Biotechnology Stocks I Performance Guide: Madrigal Pharmaceuticals, Inc. (MDGL)
MDGL has no dividends.
Table and Chart of MDGL Performance
See what a $1,000 investment in MDGL is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MDGL Returns | |
|---|---|
| Start Date | Jul-31-2014 |
| Start Price | $138.25 |
| End Date | Jul-26-2024 |
| End Price | $284.49 |
| # Prices | 121 |
| Min Date | Jul-29-2016 |
| Min Price | $7.50 |
| Max Date | Apr-28-2023 |
| Max Price | $312.00 |
| Total Return | 105.78% |
| Annualized Return | 7.42% |
| Current Value of $1,000 Purchase | $2,058 |
| Number Returns | 7,260 |
| Average Return | 295.70% |
| Number Profitable Returns | 4,892 |
| Percent Profitable Returns | 67.38% |
| Number Unprofitable Returns | 2,368 |
| Percent Unprofitable Returns | 32.62% |
| Profitable to Unprofitable Returns Ratio | 2.07 |
| MDGL Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $5,951,023,000 |
| Beta | -0.426 | Price to Sales |
| Earnings per Share | $-23.1500 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 12.24 |
| PRICE DATA | |
| 52 Week High | $299.98 |
| 52 Week Low | $119.76 |
| Analyst Target Price | $365.33 |
| 50-Day Moving Average | $262.19 |
| 200-Day Moving Average | $223.79 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -88.8% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MDGL Compare Returns with S&P 500
MDGL Trendline Chart
MDGL Moving Average Chart
MDGL Stock Return Map - See Patterns of Gains and Losses
MDGL Stock Returns/Purchase Dates